A Study to Find Out Whether BI 765423 Has an Effect on Lung Function in People With Idiopathic Pulmonary Fibrosis (IPF) With or Without Standard Treatment
Public ClinicalTrials.gov record NCT07036523. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Double-blind, Randomised, Placebo-controlled, Parallel Group, Phase IIa Trial to Evaluate Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Efficacy of BI 765423 Administered Intravenously With or Without Standard of Care in Patients With Idiopathic Pulmonary Fibrosis
Study identification
- NCT ID
- NCT07036523
- Recruitment status
- Recruiting
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 71 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 40 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Nov 12, 2025
- Primary completion
- Apr 27, 2027
- Completion
- Oct 31, 2027
- Last update posted
- May 12, 2026
2025 – 2027
United States locations
- U.S. sites
- 16
- U.S. states
- 13
- U.S. cities
- 15
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| University of Alabama at Birmingham | Birmingham | Alabama | 35233 | Not yet recruiting |
| Banner - University Medical Center Tucson | Tucson | Arizona | 85724 | Not yet recruiting |
| University of Florida | Gainesville | Florida | 32610 | Not yet recruiting |
| Renstar Medical Research | Ocala | Florida | 34470 | Recruiting |
| University of Iowa Hospitals and Clinics | Iowa City | Iowa | 52242 | Not yet recruiting |
| University of Kansas Medical Center | Kansas City | Kansas | 66103-2937 | Not yet recruiting |
| University of Minnesota | Minneapolis | Minnesota | 55455 | Not yet recruiting |
| The Lung Research Center, LLC | Chesterfield | Missouri | 63017 | Recruiting |
| University of Missouri Health System | Columbia | Missouri | 65212 | Not yet recruiting |
| Columbia University Medical Center-New York Presbyterian Hospital | New York | New York | 10032 | Recruiting |
| Weill Cornell Medical College | New York | New York | 10065 | Not yet recruiting |
| Duke University Medical Center | Durham | North Carolina | 27710 | Not yet recruiting |
| University of Cincinnati Medical Center | Cincinnati | Ohio | 45267 | Not yet recruiting |
| Temple University Hospital | Philadelphia | Pennsylvania | 19140 | Recruiting |
| Clinical Trials Center of Middle Tennessee, LLC | Franklin | Tennessee | 37067 | Recruiting |
| University of Virginia Health System | Charlottesville | Virginia | 22908 | Not yet recruiting |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 31 non-U.S. sites.
Recently updated Idiopathic Pulmonary Fibrosis trials
Other public records listing Idiopathic Pulmonary Fibrosis. Sorted by last update posted; newest first. Not a recommendation.
- NCT06325696: H01 in Adults With Interstitial Lung Disease (The SOLIS Study) Recruiting
- NCT05389215: Clinical Trial to Evaluate the Safety and Efficacy of DWN12088 in Patients With IPF Active, not recruiting
- NCT07671911: Idiopathic Pulmonary Fibrosis (IPF)-Related Chronic Cough Reduction With Nalbuphine Extended-Release (NAL ER) Tablets Recruiting
- NCT07674745: Autoantibody Reduction Therapy for Progressive Idiopathic Pulmonary Fibrosis Not yet recruiting
- NCT05241275: Xenon MRI and Progressive ILD Active, not recruiting
- NCT00470327: A Study of the Natural Progression of Interstitial Lung Disease (ILD) Recruiting
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT07036523, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted May 12, 2026 · Synced May 19, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT07036523 live on ClinicalTrials.gov.